ORMP icon

Oramed Pharmaceuticals
ORMP

Overview Fund Trends Analyst Outlook Journalist POV

88 hedge funds and large institutions have $29.6M invested in Oramed Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 24 increasing their positions, 19 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

less funds holding

Funds holding: →

41% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 34

62% less capital invested

Capital invested by funds: $78.4M → $29.6M (-$48.7M)

Holders
88
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$854K
Puts
$228K
Net Calls
Net Calls Change

Top Buyers

1
+$2.12M
2
+$1.65M
3
+$1.46M
4
E
Ergoteles
New York
+$1.03M
5
Millennium Management
Millennium Management
New York
+$993K

Top Sellers

1
-$7.75M
2
-$3.33M
3
-$2.92M
4
State Street
State Street
Massachusetts
-$2.25M
5
Nuveen Asset Management
Nuveen Asset Management
Illinois
-$1.46M
Name Holding Trade Value Shares
Change 		Change in
Stake
101
–
102
–
103
–
104
–
105
–
106
–
107
–
108
–
109
–
110
–
111
–
112
–
113
–
114
–
115
–
116
–
117
–
118
–
1 2 3 4
5